{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T15:45:18Z","timestamp":1792424718581,"version":"4.5.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T00:00:00Z","timestamp":1600041600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11255-020-02636-2","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T08:02:32Z","timestamp":1600070552000},"page":"241-248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Over-diagnosed prostate cancer in solid organ recipients: lessons from the last 3 decades"],"prefix":"10.1007","volume":"53","author":[{"given":"Thibaut","family":"Waeckel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khelifa","family":"Ait Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Belin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Doerfler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Tillou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"key":"2636_CR1","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1002\/cncr.28043","volume":"12","author":"EC Hall","year":"2013","unstructured":"Hall EC, Pfeiffer RM, Segev DL, Engels EA (2013) Cumulative incidence of cancer after solid organ transplantation. Cancer 12:2300\u20132308","journal-title":"Cancer"},{"key":"2636_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.3322\/caac.21208","volume":"64","author":"R Siegel","year":"2014","unstructured":"Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9\u201329","journal-title":"CA Cancer J Clin"},{"key":"2636_CR3","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/sj.pcan.4500519","volume":"4","author":"M Souli\u00e9","year":"2001","unstructured":"Souli\u00e9 M, Grosclaude P, Villers A, M\u00e9negoz F, Schaffer P, Mace-Lesech J, Molinier L, Sauvage-Machelard M (2001) A population-based study on management of prostate cancer in four regions of France. Prostate Cancer Prostatic Dis 4:154\u2013160","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"2636_CR4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.acuro.2017.10.005","volume":"42","author":"A Narv\u00e1ez","year":"2018","unstructured":"Narv\u00e1ez A, Suarez J, Riera L, Castells-Esteve M, Cocera R, Vigu\u00e9s F (2018) Our experience in the management of prostate cancer in renal transplant recipients. Actas Urol Esp 42:249\u2013255","journal-title":"Actas Urol Esp"},{"key":"2636_CR5","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1111\/ctr.12773","volume":"30","author":"C Pettenati","year":"2016","unstructured":"Pettenati C, Jannot A-S, Hurel S, Verkarre V, Kreis H, Housset M, Legendre C, M\u00e9jean A, Timsit M-O (2016) Prostate cancer characteristics and outcome in renal transplant recipients: results from a contemporary single center study. Clin Transplant 30:964\u2013971","journal-title":"Clin Transplant"},{"key":"2636_CR6","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.transproceed.2017.03.006","volume":"49","author":"JA Carvalho","year":"2017","unstructured":"Carvalho JA, Nunes P, Dinis PJ, Antunes H, Parada B, Marconi L, Moreira P et al (2017) Prostate cancer in renal transplant recipients: diagnosis and treatment. Transpl Proc 49:809\u2013812","journal-title":"Transpl Proc"},{"key":"2636_CR7","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1093\/ndt\/gfn008","volume":"23","author":"F Kleinclauss","year":"2008","unstructured":"Kleinclauss F, Gigante M, Neuzillet Y, Mouzin M, Terrier N, Salomon L, Iborra F et al (2008) Prostate cancer in renal transplant recipients. Nephrol Dial Transplant 23:2374\u20132380","journal-title":"Nephrol Dial Transplant"},{"key":"2636_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.euf.2018.05.010","volume":"4","author":"V Hevia","year":"2018","unstructured":"Hevia V, Boissier R, Rodr\u00edguez-Faba \u00d3, Fraser-Taylor C, Hassan-Zakri R, Lledo E, Regele H et al (2018) Management of localised prostate cancer in kidney transplant patients: a systematic review from the EAU guidelines on renal transplantation panel. Eur Urol Focus 4:153\u2013162","journal-title":"Eur Urol Focus"},{"key":"2636_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.urolonc.2015.08.020","volume":"34","author":"GE Gin","year":"2016","unstructured":"Gin GE, Pereira JF, Weinberg AD, Mehrazin R, Lerner SM, Sfakianos JP, Phillips CK (2016) Prostate-specific antigen screening and prostate cancer treatment in renal transplantation candidates: a survey of U.S. transplantation centers. Urol Oncol 34:57 (e9\u201313)","journal-title":"Urol Oncol"},{"key":"2636_CR10","doi-asserted-by":"publisher","first-page":"63","DOI":"10.14740\/wjon1191","volume":"10","author":"R Prashanth","year":"2019","unstructured":"Prashanth R (2019) Epidemiology of prostate cancer. World J Oncol 10:63\u201389","journal-title":"World J Oncol"},{"key":"2636_CR11","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1001\/jama.2011.1592","volume":"306","author":"EA Engels","year":"2011","unstructured":"Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK et al (2011) Spectrum of cancer risk among U.S. solid organ transplant recipients: the transplant cancer match study. JAMA 306:1891\u20131901","journal-title":"JAMA"},{"key":"2636_CR12","unstructured":"https:\/\/www.agence-biomedecine.fr\/rapport-annuel-REIN-2016"},{"issue":"Suppl 1","key":"2636_CR13","doi-asserted-by":"publisher","first-page":"R81","DOI":"10.1016\/j.purol.2019.01.007","volume":"28","author":"F Rozet","year":"2018","unstructured":"Rozet F, Hennequin C, Beauval JB, Beuzeboc P, Cormier L, Fromont-Hankard G, Mongiat-Artus P, Ploussard G, Mathieu R, Brureau L, Ouzzane A, Azria D, Brenot-Rossi I, Cancel-Tassin G, Cussenot O, Rebillard X, Lebret T, Souli\u00e9 M, Renard Penna R, M\u00e9jean A (2018) French ccAFU guidelines\u2014update 2018\u20132020: prostate cancer. Prog Urol 28(Suppl 1):R81\u2013R132","journal-title":"Prog Urol"},{"key":"2636_CR14","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","volume":"71","author":"N Mottet","year":"2017","unstructured":"Mottet N, Bellmunt J, Bolla M, Briers E, Cumberbatch MG, De Santis M, Fossati N, Gross T, Henry AM, Joniau S, Lam TB, Mason MD, Matveev VB, Moldovan PC, van den Bergh RCN, Van den Broeck T, van der Poel HG, van der Kwast TH, Rouvi\u00e8re O, Schoots IG, Wiegel T, Cornford P (2017) EAU-ESTRO-SIOG guidelines on prostate cancer part 1: screening, diagnosis, and local treatment with curative intent. Eur Urol 71:618\u2013629","journal-title":"Eur Urol"},{"key":"2636_CR15","unstructured":"Defossez G, Le Guyader\u2010Peyrou S, Uhry Z, Grosclaude P, Colonna M, Dantony E et al (2019) Estimations nationales de l\u2019incidence et de la mortalit\u00e9 par cancer en France m\u00e9tropolitaine entre 1990 et 2018. Synth\u00e8se. Sant\u00e9 publique France, Saint\u2010Maurice"},{"key":"2636_CR16","first-page":"S1","volume":"9","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group","year":"2009","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group (2009) KDIGO clinical practice guideline for the care of kidney transplant recipients. Am J Transplant 9:S1\u2013155","journal-title":"Am J Transplant"},{"key":"2636_CR17","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ejca.2012.09.013","volume":"49","author":"P Piselli","year":"2013","unstructured":"Piselli P, Serraino D, Segoloni GP et al (2013) Risk of de novo cancers after transplantation : results from a cohort of 7217 kidney transplant recipients, Italy 1997\u20132009. Eur J Cancer 49:336\u2013344","journal-title":"Eur J Cancer"},{"key":"2636_CR18","first-page":"20078","volume":"149","author":"E Lengwiler","year":"2019","unstructured":"Lengwiler E, Stampf S, Zippelius A, Salati E, Zaman K, Sch\u00e4fer N, Schardt J, Siano M, Hofbauer G (2019) The Swiss Transplant Cohort Study Solid cancer development in solid organ transplant recipients within the Swiss Transplant Cohort Study. Swiss Med Wkly 149:20078","journal-title":"Swiss Med Wkly"},{"key":"2636_CR19","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1111\/j.1432-2277.2006.00383.x","volume":"19","author":"M Kessler","year":"2006","unstructured":"Kessler M, Jay N, Molle R, Guillemin F (2006) Excess risk of cancer in renal transplant patients. Transpl Int 19:908\u2013914","journal-title":"Transpl Int"},{"key":"2636_CR20","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1080\/0284186X.2019.1580385","volume":"58","author":"S J\u00e4\u00e4maa-Holmberg","year":"2019","unstructured":"J\u00e4\u00e4maa-Holmberg S, Salmela B, Lemstr\u00f6m K, Pukkala E, Lommi J (2019) Cancer incidence and mortality after heart transplantation\u2014a population-based national cohort study. Acta Oncol 58:859\u2013863","journal-title":"Acta Oncol"},{"issue":"75","key":"2636_CR21","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1097\/01.TP.0000041785.38998.6C","volume":"27","author":"L Cormier","year":"2003","unstructured":"Cormier L, Lechevallier E, Barrou B, Benoit G, Bensadoun H, Boudjema K, Descottes JL, Dor\u00e9 B, Guy L, Malavaud B, Patard JJ, Petit J, Salomon L (2003) Diagnosis and treatment of prostate cancers in renal-transplant recipients. Transplantation 27(75):237\u2013239","journal-title":"Transplantation"},{"key":"2636_CR22","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s11255-011-9988-8","volume":"44","author":"S Binsaleh","year":"2012","unstructured":"Binsaleh S (2012) Diagnosis and treatment of prostate cancer in renal-transplant recipients. Int Urol Nephrol 44:149\u2013155","journal-title":"Int Urol Nephrol"},{"key":"2636_CR23","doi-asserted-by":"publisher","first-page":"298","DOI":"10.6002\/ect.2018.0048","volume":"17","author":"UH Haroon","year":"2019","unstructured":"Haroon UH, Davis NF, Mohan P, Little DM, Smyth G, Forde JC, Power RE (2019) Incidence, management, and clinical outcomes of prostate cancer in kidney transplant recipients. Exp Clin Transplant 17:298\u2013303","journal-title":"Exp Clin Transplant"},{"key":"2636_CR24","doi-asserted-by":"publisher","first-page":"1859","DOI":"10.1097\/TP.0000000000001725","volume":"101","author":"MA Mouchli","year":"2017","unstructured":"Mouchli MA, Singh S, Loftus EV Jr, Boardman L, Talwalkar J, Rosen CB, Heimbach JK, Wiesner RH, Hasan B, Poterucha JJ, Kymberly WD (2017) Risk factors and outcomes of de novo cancers (excluding nonmelanoma skin cancer) after liver transplantation for primary sclerosing cholangitis. Transplantation 101:1859\u20131866","journal-title":"Transplantation"},{"key":"2636_CR25","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/jnci\/djz221","volume":"112","author":"SL Liauw","year":"2020","unstructured":"Liauw SL, Ham SA, Das LC, Rudra S, Packiam V, Koshy M, Weichselbaum RR, Becker YT, Bodzin A, Eggener SE (2020) Prostate cancer outcomes following solid-organ transplantation: a SEER-medicare analysis. J Natl Cancer Inst 112:847\u2013854","journal-title":"J Natl Cancer Inst"},{"key":"2636_CR26","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1097\/01.ju.0000107247.81471.06","volume":"171","author":"MR Cooperberg","year":"2004","unstructured":"Cooperberg MR, Broering JM, Litwin MS, Lubeck DP, Mehta SS, Henning JM, Carroll PR, CaPSURE Investigators (2004) The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry. J Urol 171:1393\u20131401","journal-title":"J Urol"},{"key":"2636_CR27","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.2147\/DDDT.S111695","volume":"12","author":"M Grabowska","year":"2016","unstructured":"Grabowska M, K\u0119dzierska K, Michalek K, S\u0142uczanowska-G\u0142\u0105bowska S, Grabowski M, Piasecka M, Kram M, Rotter I, Ryl A, Laszczy\u0144ska M (2016) Effects of an immunosuppressive treatment on the rat prostate. Drug Des Dev Ther 12:2899\u20132915","journal-title":"Drug Des Dev Ther"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02636-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-020-02636-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-020-02636-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,14]],"date-time":"2021-09-14T00:56:54Z","timestamp":1631581014000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-020-02636-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,14]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["2636"],"URL":"https:\/\/doi.org\/10.1007\/s11255-020-02636-2","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,14]]},"assertion":[{"value":"24 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}